Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications

被引:9
|
作者
Heitel, Pascal [1 ,2 ]
机构
[1] Univ Oxford, Dept Chem, Chem Res Lab, Mansfield Rd, Oxford OX1 3TA, England
[2] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany
来源
MOLECULES | 2023年 / 28卷 / 02期
关键词
heterobifunctional molecules; proximity-inducing chimeras; targeted protein modification; conditional protein degradation; INDUCED DEGRADATION; DRUG DISCOVERY; RECEPTOR; KNOCKDOWN; RECOGNITION; THERAPY; LIGANDS; PROTACS; TAG;
D O I
10.3390/molecules28020690
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Posttranslational modifications (PTMs) play an important role in cell signaling and they are often deregulated in disease. This review addresses recent advances in the development of heterobifunctional small molecules that enable targeting or hijacking PTMs. This emerging field is spearheaded by proteolysis-targeting chimeras (PROTACs), that induce ubiquitination of their targets and, thus, tag them for degradation by the proteasome. Within the last decade, several improvements have been made to enhance spatiotemporal control of PROTAC-induced degradation as well as cell permeability. Inspired by the success story of PROTACs, additional concepts based on chimeric small molecules have emerged such as phosphatase-recruiting chimeras (PhoRCs). Herein, an overview of strategies causing (de-)phosphorylation, deubiquitination as well as acetylation is provided, and the opportunities and challenges of heterobifunctional molecules for drug discovery are highlighted. Although significant progress has been achieved, a plethora of PTMs have not yet been covered and PTM-inducing chimeras will be helpful tools for chemical biology and could even find application in pharmacotherapy.
引用
收藏
页数:28
相关论文
共 50 条
  • [1] New Developments in Targeted Analysis of Protein Posttranslational Modifications
    Braakman, Rene B. H.
    Umar, Arzu
    CURRENT PROTEOMICS, 2013, 10 (02) : 98 - 119
  • [2] Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule
    Wigle, Tim J.
    Ren, Yue
    Molina, Jennifer R.
    Blackwell, Danielle J.
    Schenkel, Laurie B.
    Swinger, Kerren K.
    Kuplast-Barr, Kristy
    Majer, Christina R.
    Church, W. David
    Lu, Alvin Z.
    Mo, Jason
    Abo, Ryan
    Cheung, Anne
    Dorsey, Bryan W.
    Niepel, Mario
    Perl, Nicholas R.
    Vasbinder, Melissa M.
    Keilhack, Heike
    Kuntz, Kevin W.
    CHEMBIOCHEM, 2021, 22 (12) : 2107 - 2110
  • [3] Targeted proteomics of myofilament phosphorylation and other protein posttranslational modifications
    Ramirez-Correa, Genaro A.
    Martinez-Ferrando, Maria Isabel
    Zhang, Pingbo
    Murphy, Anne M.
    PROTEOMICS CLINICAL APPLICATIONS, 2014, 8 (7-8) : 543 - 553
  • [4] Targeted degradation of PARP14 Using a heterobifunctional small molecule.
    Wigle, Tim
    Ren, Yue
    Molina, Jennifer
    Blackwell, Danielle
    Schenkel, Laurie
    Swinger, Kerren
    Cheug, Anne
    Abo, Ryan
    Minissale, Elena
    Lu, Alvin
    Majer, Christina
    Church, William
    Dorsey, Bryan
    Niepel, Mario
    Perl, Nicholas
    Kuplast-Barr, Kristy
    McEachern, Kristen
    Vasbinder, Melissa
    Keilhack, Heike
    Kuntz, Kevin
    CANCER RESEARCH, 2021, 81 (13)
  • [5] Targeted protein posttranslational modifications by chemically induced proximity for cancer therapy
    Peng, Yunhua
    Liu, Jing
    Inuzuka, Hiroyuki
    Wei, Wenyi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (04)
  • [6] Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies
    Yang, Yunuo
    Wu, Jiaxuan
    Zhou, Wenjun
    Ji, Guang
    Dang, Yanqi
    MEDCOMM, 2024, 5 (10):
  • [7] Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation
    Xi, Meiyang
    Chen, Yi
    Yang, Hongyu
    Xu, Huiting
    Du, Kui
    Wu, Chunlei
    Xu, Yanfei
    Deng, Liping
    Luo, Xiang
    Yu, Lemao
    Wu, Yonghua
    Gao, Xiaozhong
    Cai, Tao
    Chen, Bin
    Shen, Runpu
    Sun, Haopeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 174 : 159 - 180
  • [8] Emerging roles of targeted small molecule protein-tyrosine kinase inhibitors in cancer therapy
    Smith, JK
    Mamoon, NM
    Duhé, RJ
    ONCOLOGY RESEARCH, 2004, 14 (4-5) : 175 - 225
  • [9] Small molecule control of targeted protein degradation
    Crews, Craig M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [10] Rational Screening for Cooperativity in Small-Molecule Inducers of Protein-Protein Associations
    Liu, Shuang
    Tong, Bingqi
    Mason, Jeremy W.
    Ostrem, Jonathan M.
    Tutter, Antonin
    Hua, Bruce K.
    Tang, Sunny A.
    Bonazzi, Simone
    Briner, Karin
    Berst, Frederic
    Zecri, Frederic J.
    Schreiber, Stuart L.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2023, 145 (42) : 23281 - 23291